Eag. Blomme et al., Skeletal metastasis of prostate adenocarcinoma in rats: Morphometric analysis and role of parathyroid hormone-related protein, PROSTATE, 39(3), 1999, pp. 187-197
BACKGROUND. Prostate cancer frequently metastasizes to bone, where it induc
es osteoblastic lesions. Parathyroid hormone-related protein (PTHrP), a pro
duct of normal and neoplastic prostate cells, may promote growth and bone m
etastasis of certain types of cancer. In this study, we investigated the: 1
) pathogenesis and morphology of bone metastases in the MATLyLu rat prostat
e adenocarcinoma model, and 2) effect of PTHrP overexpression on tumor grow
th and incidence of bone metastasis.
METHODS. MATLyLu cells Mi ere stably transfected with a PTHrP expression ve
ctor or control plasmid. PTHrP expression was determined in vitro by immuno
radiometric assay and Northern blot analysis. MATLyLu cells were injected i
nto the left ventricle of Copenhagen rats to induce bone metastases. Histol
ogy and radiography were used to quantify the size and number of bone metas
tases. Serum alkaline phosphatase isoenzyme concentrations and histomorphom
etric analysis were used to evaluate bone formation and resorption.
RESULTS. All rats developed osteolytic metastases-in long bones and vertebr
ae. There was no evidence of increased intramedullary bone formation. PTHrP
overexpression by MATLyLu cells was not associated with any difference in
the incidence of bone metastasis, size of metastatic foci or tumor-cell pro
liferation.
CONCLUSIONS. The MATLyLu intracardiac injection model of prostate carcinoma
is an aggressive tumor model with a high incidence of osteolytic skeletal
metastases, and is not altered by increased PTHrP production by neoplastic
prostate epithelial cells. (C) 1999 Wiley-Liss, Inc.